Serum antioxidant status and oxidized ldl in well-controlled young type 1 diabetic patients with and without subclinical complications

Atherosclerosis

Volumn 137, Issue SUPPL., 1998, Pages

  Willems, D ^a   Dorchy, H ^b   Dufrasne, D ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

Author keywords

Diabetic patients; Oxidized LDL; Serum antioxidant

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; AUTOANTIBODY; HEMOGLOBIN A1C; OXIDIZED LOW DENSITY LIPOPROTEIN; RETINOL;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; ANTIOXIDANTS; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS, LDL; MALE;

EID: 0031802391     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00320-1     Document Type: Conference Paper

References (22)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993;329:977-86.
2. Dorchy H. Quel contrôle glycémique peut être obtenu chez des jeunes diabétiques sans sécrétion résiduelle d'insuline endogène? Quelle est la fréquence des hypoglycémies sévères et des complications subcliniques? Arch Pédiatr 1994;1:970-81.
3. Dorchy H, Roggemans MP, Willems D. Quel contrôle glycémique peut être obtenu chez des jeunes diabétiques et quelle est la fréquence des complications subcliniques? Avec 4 ans de recu supplémentaire. Arch Pédiatr 1996;3:294-6.
4. Willems D, Dorchy H. Taux des lipoprotéines et des apolipoprotéines chez les jeunes diabétiques insulinodépendants. Relation avec l'hémoglobine glycosylée et la fructosamine. Presse Méd 1990;19:17-20.
5. Willems D, Dorchy H. Sousfractions du HDL cholestérol chez les jeunes diabétiques insulinodépendants. Presse Méd 1991;20:86.
6. Willems D, Dorchy H, Dutrasne D. Serum lipoprotein(a) in type 1 diabetic children and adolescents; relationships with HbAlc and subclinical complications. Eur J Pediatr 1996;155:175-8.
7. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-67.
8. Baynes JW. The role of oxidation stress in the development of complications in diabetes. Diabetes 1991;40:405-12.
9. Ndahimana J, Dorchy H, Vertongen F. Activité anti-oxydante érythrocytaire et plasmatique dans le diabéte de type 1. Presse Méd 1996;25:188-92.
10. Dorchy H, Ndahimana J, Vertongen F. Erythrocyte and plasma antioxidant activity and subclinical complications in young diabetic patients. Diabetes Care 1996;19:1165.
11. Salonen JK, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witzum JL. Autoantibodies against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-7.
12. Asayama K, Uchida N, Nakane T, Hayashibe H, Dobashi K, Amemiya S, Kato K, Nakazawa S. Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Radic Biol Med 1993;15:597-602.
13. Elhadd TA, Hill A, Greene SA, Belch JJF. Abnormal markers of oxidative stress and antioxidant status of children, adolescents and young adults with insulin dependent diabetes mellitus. Diabetic Med 1997;14(1):26.
14. Dorchy H, Roggemans MP, Willems D. Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: a Belgian experience. Diabetes Care 1997;20:2-6.
15. Jeppsson JO, Jerntorp P, Sundkvist G, Englund H, Nylund V. Measurement of hemoglobin Alc by a new liquid chromatographic assay. Methodology, clinical utility and relation to glucose tolerance evaluated. Clin Chem 1986;32:1867-72.
16. Arnaud J, Fortis I, Blachier S, Kia D, Favier A. Simultaneous determination of retinol, α-tocopherol and β-carotene in serum by isocratic high pressure liquid chromatography. J Chromatogr 1991;572:103-16.
17. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993;84:407-12.
18. Parums DV, Brown DL, Mitchinson MJ. Serum antibodies against oxidized low density lipoproteins and ceroid in chronic periaortitis. Arch Pathol Lab Med 1990;114:383-7.
19. Esterbauer H, Strigl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
20. Ceriello A, Gingliano D, Quatraro A, Dello Russo P, Lefebvre PJ. Metabolic control may influence the increased superoxide generation in diabetic serum. Diabetic Med 1991;8:540-2.
21. Jenkins AJ, Klein RL, Chassereau CN, Hermayer KL. LDL from patients with well controlled IDDM is not susceptible to in vitro oxidation. Diabetes 1996;45:762-7.
22. Esterbauer H, Dieber-Rotheneder M, Waeg G, Puhl H, Tatzber F. Endogenous antioxidants and lipoprotein oxidation. Biochem Soc Trans 1990;18:1059-61.